Ilaris 150 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26FGHL1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,183
Award facts
- Contract value 100% obligated
- $26,182.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $26,182.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ILARIS 150 mg/ml vials. The delivery order, issued without set-aside designation, is scheduled for completion by December 23, 2025, and represents one of numerous pharmaceutical supply orders DMS Pharmaceutical has received from the Defense Logistics Agency's Medical Supply Chain division. DMS Pharmaceutical Group specializes in distributing a comprehensive range of pharmaceuticals and medical consumables to federal agencies, with particular strength in serving Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for military healthcare operations. The underlying IDC, designated SPE2DR and valued at $499.9 million, was awarded on November 13, 2025, with a performance period extending through December 31, 2036. The contract authorizes the Defense Logistics Agency to issue multiple firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within this broader pharmaceutical supply framework.
Quick answers
Who was awarded contract SPE2DR26FGHL1?
SPE2DR26FGHL1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FGHL1 worth?
The government has obligated $26,183 on SPE2DR26FGHL1.
Is contract SPE2DR26FGHL1 an order under another contract?
Yes. SPE2DR26FGHL1 is a delivery order under SPE2DR25D9363, an indefinite delivery contract.
Was contract SPE2DR26FGHL1 competed?
The extent of competition for SPE2DR26FGHL1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award